Very High Risk of Recurrent Cardiovascular Events in Indonesian Patients with Established Coronary Heart Disease

D. S. Arsyad, Steven H J Hageman, N. Qalby, Ansariadi, Wahiduddin, A. Qanitha, Idar Mappangara, P. Doevendans, F. Visseren, M. Cramer
{"title":"Very High Risk of Recurrent Cardiovascular Events in Indonesian Patients with Established Coronary Heart Disease","authors":"D. S. Arsyad, Steven H J Hageman, N. Qalby, Ansariadi, Wahiduddin, A. Qanitha, Idar Mappangara, P. Doevendans, F. Visseren, M. Cramer","doi":"10.15420/japsc.2023.04","DOIUrl":null,"url":null,"abstract":"Background: Risk prediction for recurrent cardiovascular events and death is advocated by prevention guidelines. Using the recently updated Secondary Manifestations of ARTerial disease (SMART)2 risk score algorithm – recalibrated and validated for the Asian population – we aim to describe the 10-year risk of recurrent events among coronary heart disease (CHD) patients, and to estimate the achievable residual risk after modifying the risk factors according to national guidelines. Methods: Patients at Makassar Cardiac Center Hospital, Indonesia, with established CHD were included. The 10-year recurrent event risk, residual risk and potential absolute risk reduction obtained with risk-factor reduction (systolic blood pressure <140 mmHg, LDL cholesterol <1.8 mmol/l, smoking cessation and use of antithrombotics) was estimated using the SMART2 risk score. Results: In total, 395 CHD patients were enrolled (mean age 57 ± 12 years; 64% men). The 10-year risk of recurrent events in the baseline was 36% (interquartile range 27–51); 65% of participants were considered as very high risk (risk ≥30%). If the risk factors were modified to the optimal targets, the residual risk would decrease to 23% (interquartile range 17–34). Nevertheless, one-third of patients remain in the very high risk category. Conclusion: The risk of recurrent events is extremely high in Indonesian CHD patients. Intensive preventive actions are required to reduce these extremely high risks, but a single, one-size approach is inappropriate due to the large variation in residual risks. Identifying patients that may benefit the most from intensified treatment is crucial, especially in regions where secondary prevention agents are often limited.","PeriodicalId":321604,"journal":{"name":"Journal of Asian Pacific Society of Cardiology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Asian Pacific Society of Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/japsc.2023.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Risk prediction for recurrent cardiovascular events and death is advocated by prevention guidelines. Using the recently updated Secondary Manifestations of ARTerial disease (SMART)2 risk score algorithm – recalibrated and validated for the Asian population – we aim to describe the 10-year risk of recurrent events among coronary heart disease (CHD) patients, and to estimate the achievable residual risk after modifying the risk factors according to national guidelines. Methods: Patients at Makassar Cardiac Center Hospital, Indonesia, with established CHD were included. The 10-year recurrent event risk, residual risk and potential absolute risk reduction obtained with risk-factor reduction (systolic blood pressure <140 mmHg, LDL cholesterol <1.8 mmol/l, smoking cessation and use of antithrombotics) was estimated using the SMART2 risk score. Results: In total, 395 CHD patients were enrolled (mean age 57 ± 12 years; 64% men). The 10-year risk of recurrent events in the baseline was 36% (interquartile range 27–51); 65% of participants were considered as very high risk (risk ≥30%). If the risk factors were modified to the optimal targets, the residual risk would decrease to 23% (interquartile range 17–34). Nevertheless, one-third of patients remain in the very high risk category. Conclusion: The risk of recurrent events is extremely high in Indonesian CHD patients. Intensive preventive actions are required to reduce these extremely high risks, but a single, one-size approach is inappropriate due to the large variation in residual risks. Identifying patients that may benefit the most from intensified treatment is crucial, especially in regions where secondary prevention agents are often limited.
印尼已确诊冠心病患者心血管事件复发风险极高
背景:预防指南提倡对复发性心血管事件和死亡进行风险预测。使用最近更新的动脉疾病继发表现(SMART)2风险评分算法-在亚洲人群中重新校准和验证-我们旨在描述冠心病(CHD)患者10年复发事件的风险,并根据国家指南修改危险因素后估计可实现的剩余风险。方法:纳入印度尼西亚望加锡心脏中心医院确诊的冠心病患者。使用SMART2风险评分估计10年复发事件风险、剩余风险和潜在绝对风险降低,风险因素降低(收缩压<140 mmHg, LDL胆固醇<1.8 mmol/l,戒烟和使用抗血栓药物)。结果:共纳入395例冠心病患者(平均年龄57±12岁;64%的男性)。基线10年复发事件的风险为36%(四分位数范围27-51);65%的参与者被认为是非常高风险(风险≥30%)。如果将危险因素修改为最优目标,剩余风险将降低到23%(四分位数间距为17-34)。然而,三分之一的患者仍然处于高危类别。结论:印尼冠心病患者的复发风险极高。需要采取密集的预防措施来降低这些极高的风险,但由于剩余风险的变化很大,单一的、单一的方法是不合适的。确定可能从强化治疗中获益最多的患者至关重要,特别是在二级预防药物往往有限的地区。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信